Search Results - "Kalid, O."

Strigol1/albumin/chitosan nanoparticles decrease cell viability, induce apoptosis and alter metabolomics profile in HepG2 cancer cell line by Al-Malki, Abdulrahman L, Bakkar, Ashraf, Huwait, Etimad A, Barbour, Elie K, Abulnaja, Kalid O, Kumosani, Taha A, Moselhy, Said S

“…Hepatocellular carcinoma is one of the most common causes of cancer-related deaths globally. Bioavailable, effective and safe therapeutic agents are urgently…”
Get full text

Retraction notice to "Strigol1/albumin/chitosan nanoparticles decrease cell viability, induce apoptosis and alter metabolomics profile in HepG2 cancer cell line" [Biomed. Pharmacother. 142 (2021) 111960] by Al-Malki, Abdulrahman L., Bakkar, Ashraf, Huwait, Etimad A., Barbour, Elie K., Abulnaja, Kalid O., Kumosani, Taha A., Moselhy, Said S.

Get full text

Management of Hyperglycaemia by Ethyl Acetate Extract of Balanites aegyptiaca (Desert Date) by Al-Malki, Abdulrahman L, Barbour, Elie K, Abulnaja, Kalid O, Moselhy, Said S

“…Reactive oxygen species play a significant role in the pathogenesis of retinopathy in diabetes patients. The current study aimed to assess the effect of ethyl…”
Get full text

Thermoacoustic micro-electricity generator for rural dwellings in developing countries driven by waste heat from cooking activities by Abdoulla-Latiwish, Kalid O.A., Mao, Xiaoan, Jaworski, Artur J.

“…Thermoacoustic engines convert heat into acoustic power without moving parts. Coupling them with electrodynamic transducers – directly converting acoustic…”
Get full text

Cytotoxic and protective DNA damage of three new diterpenoids from the brown alga Dictoyota dichotoma by Ayyad, Seif-Eldin N., Makki, Mohamed S., Al-kayal, Nazeeha S., Basaif, Salim A., El-Foty, Kalid O., Asiri, Abdullah M., Alarif, Walied M., Badria, Farid A.

“…Three new diterpenes Amijiol acetate (3), dolabellane, Dolabellatrienol (4), and dolastane, Amijiol-7, 10-diacetate (9) were isolated together with the…”
Get full text

492 Quantification of exportin-1 (XPO1) occupancy by selective inhibitors of nuclear export (SINE) by Crochiere, M, Klebanov, B, Baloglu, E, Kalid, O, Kashyap, T, Senapedis, W, del Alamo, D, Tamir, S, McCauley, D, Carlson, R, Kauffman, M, Shacham, S, Landesman, Y

Get full text

G protein coupled receptors -in silico drug discovery and design by Sela, I, Golan, G, Strajbl, M, Rivenzon-Segal, D, Bar-Haim, S, Bloch, I, Inbal, B, Shitrit, A, Ben-Zeev, E, Fichman, M, Markus, Y, Marantz, Y, Senderowitz, H, Kalid, O

“…In silico drug discovery is a complex process requiring flexibility and ingenuity in method selection and a careful validation of work protocols. GPCR in…”
Get more information

BALANITES AEGYPTIACA PROTECTION AGAINST PROLIFERATION OF DIFFERENT CANCER CELL LINE by Al-Malki, Abdulrahman L, Barbour, Elie K, Abulnaja, Kalid O, Moselhy, Said S, Kumosani, Taha A, Choudhry, Hani

“…Backgroud: The aim of the present study was to evaluate in vivo anti-tumor activity of Balanites aegyptiaca fruits extracts in addition to its role in cell…”
Get full text

Two-stage travelling-wave thermoacoustic electricity generator for rural areas of developing countries by Abdoulla-Latiwish, Kalid O.A., Jaworski, Artur J.

“…•Low-cost approach to thermoacoustic electricity generator for rural communities.•Numerical study of two-stage system with loudspeaker as linear alternator…”
Get full text

RETRACTED: Strigol1/albumin/chitosan nanoparticles decrease cell viability, induce apoptosis and alter metabolomics profile in HepG2 cancer cell line by Al-Malki, Abdulrahman L., Bakkar, Ashraf, Huwait, Etimad A., Barbour, Elie K., Abulnaja, Kalid O., Kumosani, Taha A., Moselhy, Said S.

Get full text

Retraction notice to "Strigol1/albumin/chitosan nanoparticles decrease cell viability, induce apoptosis and alter metabolomics profile in HepG2 cancer cell line" Biomed. Pharmacother. 142 (2021) 111960 by Al-Malki, Abdulrahman L, Bakkar, Ashraf, Huwait, Etimad A, Barbour, Elie K, Abulnaja, Kalid O, Kumosani, Taha A, Moselhy, Said S

Get full text

386PPRECLINICAL EVALUATION OF NOVEL PAK4 ALLOSTERIC MODULATORS AGAINST TRIPLE NEGATIVE BREAST CANCER by Senapedis, W., McCauley, D., Landesman, Y., Kalid, O., Ellis, J., Carlson, R., Shacham, S., Baloglu, E.

“…Abstract Aim: Triple Negative Breast Cancer (TNBC) is characterized by a lack of receptors for estrogen (ER), progesterone (PR), and hormone epidermal growth…”
Get full text

Preclinical Evaluation of Novel Pak4 Allosteric Modulators Against Triple Negative Breast Cancer by Senapedis, W., McCauley, D., Landesman, Y., Kalid, O., Ellis, J., Carlson, R., Shacham, S., Baloglu, E.

Get full text

G Protein-Coupled Receptors: In silico Drug Discovery in 3D by Becker, Oren M., Marantz, Yael, Shacham, Sharon, Inbal, Boaz, Heifetz, Alexander, Kalid, Ori, Bar-Haim, Shay, Warshaviak, Dora, Fichman, Merav, Noiman, Silvia, Levitt, Michael

“…The application of structure-based in silico methods to drug discovery is still considered a major challenge, especially when the x-ray structure of the target…”
Get full text

PREDICT modeling and in-silico screening for G-protein coupled receptors by Shacham, Sharon, Marantz, Yael, Bar-Haim, Shay, Kalid, Ori, Warshaviak, Dora, Avisar, Noa, Inbal, Boaz, Heifetz, Alexander, Fichman, Merav, Topf, Maya, Naor, Zvi, Noiman, Silvia, Becker, Oren M.

“…G‐protein coupled receptors (GPCRs) are a major group of drug targets for which only one x‐ray structure is known (the nondrugable rhodopsin), limiting the…”
Get full text